Summary
This prediction ended on 05.08.11 with a price of €1.72. The prediction for Evotec SE closed with a convincing performance of -24.16%. Sievi has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | -29.167% | -29.167% | -43.861% | -72.717% |
iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by Sievi for this prediction
In the thread Evotec AG diskutieren
Abwärtstrend stabil
Seit beginn des Jahres verliert die Aktie kontinuierlich an Wert. Eine Bewegung, die sich vermutlich auch in den nächsten Wochen fortsetzen wird.